Abstract
Ethnopharmacological relevance Stingless bee honey is a natural remedy and therapeutic agent traditionally used by indigenous communities across the (sub-)Tropics. Despite the potential of forest honey, a prime non-timber forest product (NTFP), to revitalize indigenous foodways and to generate income in rural areas, reports on Traditional Ecological Knowledge involving stingless bees and their honey are lacking in Sub-Saharan Africa. Aim of the study: Our aim was to explore, understand and document the non-food uses of stingless bee honey and associated empirical knowledge in Kenya’s only tropical rainforest at Kakamega.
Materials and Methods We used ethnographic techniques and methods, including semi-structured questionnaires and recording devices.
Results People in Kakamega were able to discriminate between six different stingless bee species and provided an account on species-specific uses of honeys. Collectively, we identified 26 different uses.
Conclusion Stingless bee honey is essential in traditional (folk) medicine, but also in the cultural and spiritual life of indigenous communities in Kakamega.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Fonds National de la Recherche Scientifique (F.R.S-FNRS) through a Projet de Recherches (PDR)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of International Center of Insects Physiology and Ecology (Nairobi) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.